Fostamatinib for persistent/chronic adult immune thrombocytopenia.

about

Fostamatinib for the Treatment of Adult Persistent and Chronic Immune Thrombocytopenia: Results of Two Phase 3, Randomized, Placebo-Controlled Trials.Spleen tyrosine kinase inhibition: a new promising approach to chronic and refractory immune thrombocytopenia.

P2860

Q52562217-C9C8CCAF-16A6-4DEB-B346-23BC7B4AEA0F Q52764290-544782AD-0975-498A-B271-8A6995BBDB6D

P2860

Fostamatinib for persistent/chronic adult immune thrombocytopenia.

Item

http://www.wikidata.org/entity/Q54144290

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Fostamatinib for persistent/chronic adult immune thrombocytopenia.

@en

Fostamatinib for persistent/chronic adult immune thrombocytopenia.

@nl

type

Item

label

Fostamatinib for persistent/chronic adult immune thrombocytopenia.

@en

Fostamatinib for persistent/chronic adult immune thrombocytopenia.

@nl

prefLabel

Fostamatinib for persistent/chronic adult immune thrombocytopenia.

@en

Fostamatinib for persistent/chronic adult immune thrombocytopenia.

@nl

P1476

Fostamatinib for persistent/chronic adult immune thrombocytopenia.

@en

P2093

Adrian Newland

http://www.w3.org/2001/XMLSchema#string

Eun-Ju Lee

http://www.w3.org/2001/XMLSchema#string

Vickie McDonald

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

Immune thrombocytopenia

How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment

Piecing together the humoral and cellular mechanisms of immune thrombocytopenia

T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura

International consensus report on the investigation and management of primary immune thrombocytopenia

An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen

A critical role for Syk in signal transduction and phagocytosis mediated by Fcgamma receptors on macrophages

P304

9-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT-2017-0097

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

James B Bussel

P577

2017-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28967793

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia

Fostamatinib for persistent/chronic adult immune thrombocytopenia.

about

P2860

P2860

Fostamatinib for persistent/chronic adult immune thrombocytopenia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921